ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

NIH To Sponsor Animal Care, Human Protection Workshop

February 21, 1986

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Excerpts From Potti’s Application to Practice Medicine In South Carolina

December 9, 2011

Obama Promises To Double NIH Budget; McCain Offers “Necessary Funding.”

September 12, 2008

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007